Abstract:Abstract Objectives Monitoring quality control for a laboratory or network with multiple instruments measuring the same analyte is challenging. We present a retrospective assessment of a method to detect medically significant out-of-control error conditions across a group of instruments measuring the same analyte. The purpose of the model was to ensure that results from any of several instruments measuring the same analytes in a laboratory or a network of laboratories provide comparable results and reduce patient risk. Limited literature has described how to manage QC in these very common situations. Methods Single Levey–Jennings control charts were designed using peer group target mean and control limits for five common clinical chemistry analytes in a network of eight analyzers in two different geographical sites. The QC rules used were 1 3s /2 2s /R 4s , with the mean being a peer group mean derived from a large population of the same instrument and the same QC batch mean and a group CV. The peer group data used to set the target means and limits were from a quality assurance program supplied by the instrument supplier. Both statistical and clinical assessments of significance were used to evaluate QC failure. Instrument bias was continually monitored. Results It was demonstrated that the biases of each instrument were not statistically or clinically different compared to the peer group’s average over six months from February 2023 until July 2023. Over this period, the error rate determined by the QC model was consistent with statistical expectations for the 1 3s /2 2s /R 4s rule. There were no external quality assurance failures, and no detected error exceeded the TEa (medical impact). Thus, the combined statistical/clinical assessment reduced unnecessary recalibrations and the need to amend results. Conclusions This paper describes the successful implementation of a quality control model for monitoring a network of instruments, measuring the same analytes and using externally provided quality control targets. The model continually assesses individual instrument bias and imprecision while ensuring all instruments in the network meet clinical goals for quality. The focus of this approach is on detecting medically significant out-of-control error conditions.

Quality Controls in Ligand Binding Assays: Recommendations and Best Practices for Preparation, Qualification, Maintenance of Lot to Lot Consistency, and Prevention of Assay Drift.

Characterization of Critical Reagents in Ligand-Binding Assays: Enabling Robust Bioanalytical Methods and Lifecycle Management

Internal quality control: best practice

Quality Control in Clinical Biochemistry Laboratory-A Glance

International Council for Standardization in Haematology Guidance for New Lot Verification of Coagulation Reagents, Calibrators, and Controls

Internal quality control – past, present and future trends

Quality by Design for Preclinical In Vitro Assay Development

Quality control in the Netherlands; todays practices and starting points for guidance and future research

Analytical Quality by Design, Life Cycle Management, and Method Control

Quality By Design (QbD): A Comprehensive Understanding and Implementation In Pharmaceuticals Development

Internal Quality Control in Hemostasis Assays

Quality-by-Design Principles Applied to the Establishment of a Pharmaceutical Quality Control Laboratory in a Resource-Limited Setting: The Lab Water

Internal Quality Controls in the Medical Laboratory: A Narrative Review of the Basic Principles of an Appropriate Quality Control Plan

Quality Control in the Mass Spectrometry Proteomics Core: a Practical Primer

Practical Considerations of Applying Traceability Concepts to the Internal Quality Control Materials for Trueness Verification in Medical Laboratories

Quality by Design (QbD) in pharmaceutical development: A comprehensive review

A model for managing quality control for a network of clinical chemistry instruments measuring the same analyte

ICSH guidance for internal quality control policy for blood cell counters

Precision quality control: a dynamic model for risk-based analysis of analytical quality

Assessment on the validity of biochemical determination results after internal quality control out-of-control

Best Practices in qPCR and dPCR Validation in Regulated Bioanalytical Laboratories